New Approaches to Drug Circulation

5 June, 10:00–11:30 Congress Centre, zone B, 2nd floor, conference hall B4
Broadcast
The challenges Russia has faced in recent years have shown that the development, registration, and commercialization of medicines can be significantly accelerated without compromising safety and quality. This experience is being actively used today. Regulatory changes are not only taking place in Russia, but throughout the entire Eurasian Economic Union. The general processes associated with the circulation of drugs are functioning and continue to be refined. A system to monitor the movement of medicines has been introduced, which makes it possible to control the supply of drugs, verify the availability of medicines in the regions, track the journey of products from the manufacturing plant to the pharmacy and the hospital, and guarantee its authenticity. Another important aspect is the growth of e-commerce in the drug market and the need for comprehensive control to prevent the threat of illegal sales of drugs to the public. The supervisory authorities continue to focus on the quality and safety of medical care in primary healthcare and whether drug prescriptions are provided in accordance with clinical recommendations. What advantages does a unified market for drugs provide for all participants in the pharmaceutical market? What prospects exist for the development and use of a system to monitor the movement of medicines? How is transparency and safety ensured in the online pharmaceuticals sector and what prospects does it offer for patient comfort? What is the role of drug therapy in clinical guidelines? Would the standardization of processes affect the quality of medical care?

Broadcast

Image